ArticleExpert review of vaccines2012
A novel genetically engineered Mycobacterium smegmatis-based vaccine promotes anti-TB immunity.
Mangalakumari Jeyanathan et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it